When it comes to conflicts of interest, the US Food and Drug Administration says appearances count.
For the first time, the agency issued on Tuesday a draft guidance spelling out circumstances when the appearance of a conflict of interest may preclude someone from serving on one of its expert advisory panels. Until now, the FDA had only circulated guidance for determining when an actual conflict exists.